0001596274-15-000002.txt : 20150818 0001596274-15-000002.hdr.sgml : 20150818 20150818163415 ACCESSION NUMBER: 0001596274-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150818 DATE AS OF CHANGE: 20150818 EFFECTIVENESS DATE: 20150818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immusoft Corp CENTRAL INDEX KEY: 0001596274 IRS NUMBER: 271394946 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-246031 FILM NUMBER: 151061713 BUSINESS ADDRESS: STREET 1: 2800 ELLIOTT AVENUE STREET 2: SUITE 414 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 206-397-0028 MAIL ADDRESS: STREET 1: 2800 ELLIOTT AVENUE STREET 2: SUITE 414 CITY: SEATTLE STATE: WA ZIP: 98121 D 1 primary_doc.xml X0707 D LIVE 0001596274 Immusoft Corp 2800 ELLIOTT AVENUE SUITE 414 SEATTLE WA WASHINGTON 98121 206-397-0028 DELAWARE None None Corporation true Matthew Scholz c/o Immusoft Corporation 2800 Elliott Avenue, Suite 414 Seattle WA WASHINGTON 98121 Executive Officer Director Mark Ahn, Ph.D. c/o Immusoft Corporation 2800 Elliott Avenue, Suite 414 Seattle WA WASHINGTON 98121 Director Biotechnology Decline to Disclose 06b false 2015-08-03 false true true Convertible Promissory Notes and the underlying equity securities issuable upon conversion thereof false 0 1000000 375000 625000 false 3 0 0 0 true false Immusoft Corp /s/ Matthew Scholz Matthew Scholz Chief Executive Officer 2015-08-18